Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240038/S003

FINEVISION HP Trifocal IOLs

Beaver-Visitec International, Inc. · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONP240038/S003

What did the FDA approve?

The FDA database lists decision APPR dated 2026-09-25 for P240038/S003, a Real-Time Process supplement to the FINEVISION HP Trifocal intraocular lens PMA filed by Beaver Visitec International, Inc. The supplement reason is recorded as "Labeling Change - Indications/instructions/shelf life/tradename," and the recorded specialty is Ophthalmic under product code HQL. The supplement number establishes this as a change to the existing P240038 PMA rather than a new approval of the whole lens system.

The reported statement covers an extension of device shelf life from 3 years to 5 years and an expanded storage condition range to 2-35°C. Beyond those two labeling parameters, the supplied fields do not describe the original PMA scope, the prior storage range, or the evidence supporting the change, so the basis for the decision cannot be assessed from this record. The statement documents a reported purpose only and does not establish safety or clinical effectiveness.

FDA approval order statement

approval for an extension of the device shelf life from 3 years to 5 years, and expanded storage condition range to 2-35°C, for the FINEVISION HP Trifocal intraocular lens.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Ophthalmic
Decision date
Sep 25, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P240038/S003
Regulatory pathway
PMA supplement
Product code
HQL
Decision code
APPR
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Product code
HQL
FDA device class
3

For the original device and its historical approval scope, see PMA P240038. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P240038 · Original PMA

    FINEVISION HP Trifocal IOLs

  2. P240038/S003 received

    Application receipt date recorded by FDA.

  3. P240038/S003 · FDA decision

    Real-Time Process

  4. P240038/S004 · Related supplement

    FINEVISION HP Trifocal IOLs

Timeline entries are records held by MedtechLedger for P240038. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240038

Product / regulatory recordCompanyPathwayDecision dateSource
Beaver-Visitec International, Inc.PMA approvalSep 10, 2025FDA
Beaver-Visitec International, Inc.PMA supplementOct 27, 2026FDA

Explore the linked device profile

Other records with product code HQL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Beaver-Visitec International, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
500 Totten Pond Rd., Waltham, MA, 02451

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records